2016 Innovation Grants - Dr Petranel Ferrao

New therapeutic tools
Dr Petranel Ferrao Panel Image

Dr Petranel Ferrao

Grant

Utilising a novel predictor to stratify patients with therapy-resistant pancreatic cancer for treatment with CHK inhibitor drugs to improve responses and outcomes

Award

2016 Innovation Grant

Institution

The University of Melbourne

Pancreatic cancer patients have very low survival rates and desperately need new therapies to improve outcomes. We have identified a marker that may be useful for identifying some cancers that are responsive to new targeted CHK inhibitor drugs. We will utilise pancreatic cancer laboratory models and patient samples to validate this marker, so that it can be used to select pancreatic cancer patients who will benefit from these drugs to enhance treatment responses, improve outcomes and in-turn increase patient survival rates.

Dr Petranel Ferrao Panel Image

Dr Petranel Ferrao, University of Melbourne

Research Reports
Click to download progress reporting on the outcomes of this research: